Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

Antidepressants that are more efficient and faster

05.02.2008
In the PhD defended by the pharmacologist and biochemist Jorge Emilio Ortega Calvo at the University of the Basque Country, a new anti-depressant treatment strategy is proposed that is capable of improving on the current one with its drawbacks.

Depression is a chronic and recurrent illness that can affect at least 20% of the population at some period in their lifetime, according to a number of studies carried out. Moreover, according to the WHO, by 2020 emotional state disorders could be the foremost or second cause for sick leave from work in the developed countries. Current ant-depressive therapies, nevertheless, are far from optimum.

This was the theme of the PhD presented by the pharmacologist and biochemist from the Basque province of Gipuzkoa, Jorge Emilio Ortega Calvo, undertaken at the Faculty of Medicine and Odontology of the University of the Basque Country (UPV/EHU). Basically it was a study in which an analysis was undertaken of the action mechanisms of current antidepressant pharmacological drugs and new antidepressant treatment strategies put forward and that could be useful in the near future in order to address the failings in the current ones.

The PhD entitled, Nuevas estrategias de potenciación antidepresiva basadas en la interacción entre los sistemas noradrenérgico y serotonérgico centrales. Estudio mediante microdiálisis cerebral in vivo (New strategies of antidepressive boosting based on the interaction between the central noradrenergic and serotonergic systems. A study using in vivo cerebral microdialysis) was directed by Professor of Pharmacology, José Javier Meana Martínez and lecturer in Pharmacology, Luis Felipe Callado Hernando, and which obtained excellent cum laude. While carrying out the PhD, Mr Ortega had the opportunity to spend time at a pharmaceutical multinational in the United States, concretely at the Eli Lilly Laboratories.

... more about:
»Ortega »PhD »braking »cerebral »strategies

Jorge Emilio Ortega Calvo graduated in Pharmacy and Biochemistry from the UPV/EHU and is currently carrying out research in the pharmacological laboratory at the University.

Greater braking effect than normal

What this study proposes is, on the one hand, to make advances in our knowledge about a highly prevalent illness – depression - which is still largely of unknown etiology and, on the other, to develop treatment strategies that are more efficacious than the current ones.

Depression is mainly related to disorders with or deficiencies of the neurotransmitters, noradrenaline and serotonine. In the process of depression, the levels of noradrenaline and serotonine in a number of cerebral areas are altered. The task of anti-depressive drugs is to balance, as it were, these levels. However, the biggest drawback in the current treatment of this illness is that only 60-70% of patients respond to treatment. Moreover, when a person starts to be treated, they normally require at least between two and four weeks before symptoms begin to improve and, on not observing any type of short-term improvement, many stop taking the medication.

Due to this, the aim of this PhD was to study the action mechanisms of these drugs in order to, on the one hand, identify treatments that act from the start and, on the other, try to improve the situation for patients who in principle do not respond to this treatment.

To this end, the usual treatments are combined with new targets – the antagonist pharmaceutical drugs of the adrenoceptors a2 that help to boost or increase neurotransmission existing in the brain. Given that it has been observed that in post-mortem brains of patients previously diagnosed with depression and who had committed suicide, these adrenoceptors were found to be altered, their function increased and there was a greater braking effect than normal. This braking impeded the neurotransmission systems from functioning correctly. “If we stop this greater braking effect in those persons suffering depression, it could be that the anti-depressive pharmacological drug might start to act”, he added.

The approach to this study involved animals using the technique of in vivo cerebral microdialysis; “that is, using surgery we introduce probes in certain cerebral zones, and we collected and measured the amount of neurotransmitters in these areas, in order to subsequently see how they are modified on administering different pharmaceutical drugs”.

The results of the thesis point to the fact that the new strategies proposed are able, on the one hand, of improving the percentage response as regards the number of persons responding to treatment and, on the other, of shortening the time period between the initiation of treatment and therapeutic response. “Which may indicate that if all this is taken to the level of a clinical study and trials with patients suffering from depression are begun, perhaps there will be a faster response and amongst a greater number of patients” he stated.

Irati Kortabitarte | alfa
Further information:
http://www.basqueresearch.com/berria_irakurri.asp?Berri_Kod=1616&hizk=I

Further reports about: Ortega PhD braking cerebral strategies

More articles from Life Sciences:

nachricht Scientists uncover the role of a protein in production & survival of myelin-forming cells
19.07.2018 | Advanced Science Research Center, GC/CUNY

nachricht NYSCF researchers develop novel bioengineering technique for personalized bone grafts
18.07.2018 | New York Stem Cell Foundation

All articles from Life Sciences >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: First evidence on the source of extragalactic particles

For the first time ever, scientists have determined the cosmic origin of highest-energy neutrinos. A research group led by IceCube scientist Elisa Resconi, spokesperson of the Collaborative Research Center SFB1258 at the Technical University of Munich (TUM), provides an important piece of evidence that the particles detected by the IceCube neutrino telescope at the South Pole originate from a galaxy four billion light-years away from Earth.

To rule out other origins with certainty, the team led by neutrino physicist Elisa Resconi from the Technical University of Munich and multi-wavelength...

Im Focus: Magnetic vortices: Two independent magnetic skyrmion phases discovered in a single material

For the first time a team of researchers have discovered two different phases of magnetic skyrmions in a single material. Physicists of the Technical Universities of Munich and Dresden and the University of Cologne can now better study and understand the properties of these magnetic structures, which are important for both basic research and applications.

Whirlpools are an everyday experience in a bath tub: When the water is drained a circular vortex is formed. Typically, such whirls are rather stable. Similar...

Im Focus: Breaking the bond: To take part or not?

Physicists working with Roland Wester at the University of Innsbruck have investigated if and how chemical reactions can be influenced by targeted vibrational excitation of the reactants. They were able to demonstrate that excitation with a laser beam does not affect the efficiency of a chemical exchange reaction and that the excited molecular group acts only as a spectator in the reaction.

A frequently used reaction in organic chemistry is nucleophilic substitution. It plays, for example, an important role in in the synthesis of new chemical...

Im Focus: New 2D Spectroscopy Methods

Optical spectroscopy allows investigating the energy structure and dynamic properties of complex quantum systems. Researchers from the University of Würzburg present two new approaches of coherent two-dimensional spectroscopy.

"Put an excitation into the system and observe how it evolves." According to physicist Professor Tobias Brixner, this is the credo of optical spectroscopy....

Im Focus: Chemical reactions in the light of ultrashort X-ray pulses from free-electron lasers

Ultra-short, high-intensity X-ray flashes open the door to the foundations of chemical reactions. Free-electron lasers generate these kinds of pulses, but there is a catch: the pulses vary in duration and energy. An international research team has now presented a solution: Using a ring of 16 detectors and a circularly polarized laser beam, they can determine both factors with attosecond accuracy.

Free-electron lasers (FELs) generate extremely short and intense X-ray flashes. Researchers can use these flashes to resolve structures with diameters on the...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

VideoLinks
Industry & Economy
Event News

Leading experts in Diabetes, Metabolism and Biomedical Engineering discuss Precision Medicine

13.07.2018 | Event News

Conference on Laser Polishing – LaP: Fine Tuning for Surfaces

12.07.2018 | Event News

11th European Wood-based Panel Symposium 2018: Meeting point for the wood-based materials industry

03.07.2018 | Event News

 
Latest News

Global study of world's beaches shows threat to protected areas

19.07.2018 | Earth Sciences

New creepy, crawly search and rescue robot developed at Ben-Gurion U

19.07.2018 | Power and Electrical Engineering

Metal too 'gummy' to cut? Draw on it with a Sharpie or glue stick, science says

19.07.2018 | Materials Sciences

VideoLinks
Science & Research
Overview of more VideoLinks >>>